Concentration levels of IL-10 and TNFα cytokines in patients with human papilloma virus (HPV) DNA+ and DNA- cervical lesions

Journal of Immunotoxicology

Volumn 9, Issue 2, 2012, Pages 168-172

  Ali, Katan Sabir ^a   Ali, Hisham Y M ^b,d   Jubrael, Jaladet M S ^c  

^a HAWLER MEDICAL UNIVERSITY   (Iraq)

^b FOUNDATION OF TECHNICAL EDUCATION   (Iraq)

^c UNIVERSITY OF DUHOK   (Iraq)

^d MINISTRY OF HIGHER EDUCATION AND SCIENTIFIC RESEARCH   (Iraq)

Author keywords

Cervical lesions; Human papilloma virus (HPV) DNA; IL 10; TNF

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CERVICAL LESION; CERVICAL SECRETIONS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IRAQ; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECRETIONS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; WART VIRUS;

ADENOCARCINOMA; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

HUMAN PAPILLOMAVIRUS;

EID: 84861075218     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2011.642419     Document Type: Article

References (23)

1. Azar K. K., Tani M., Yasuda H., Sakai A., Inoue M., and Sasagawa T. 2004. Increased secretion patterns of IL-10 and TNFa in cervical squamous intraepithelial lesions. Hum. Pathol. 35:1376-1384.
2. Bais A. G., Beckmann I., Ewing P. C., Eijkemans M. J., Meijer C. J., Snijders P. J., and Helmerhorst T. J. 2007. Cytokine release in HR-HPV+ women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV-controls. Med. Inflamm. 2007:24147.
3. Bais A. G., Beckmann I., Lindemans J., Ewing P. C., Meijer C. J., Snijders P. J., and Helmerhorst T. J. 2005. A shift to a peripheral TH2-Type cytokine pattern during the carcino-genesis of cervical cancer becomes manifest in CIN III lesions. J. Clin. Pathol. 58:1096-1100.
4. Behbakht K., Friedman J., Heimler I., Aroutcheva A., Simoes J., and Faro S. 2002. Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: A case-control study. Infect. Dis. Obstet. Gynecol. 10:181-186.
5. Bhairavabhotla R. K., Verma V., Tongaonkar H., Shstri S., Dinshaw K., and Chiplunkar S. 2007. Role of IL-10 in immune suppression. Indian J. Biochem. Biophys. 44:350-356.
6. Castle P. E., Hildesheim A., Bowman F. P., Strickler H. D., Walker J. L., Pustilnik T., Edwards R. P., and Crowley-Nowick P. A. 2002. Cervical concentrations of IL-10 and IL-12 do not correlate with plasma levels. J. Clin. Immunol. 22:23-27.
7. Clerici M., Merola M., Ferrario E., Trabattoni D., Villa M. L., Stefanon B., Venzon D. J., Shearer G. M., de Palo G., and Clerici E. 1997. Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papillomavirus infection. J. Natl. Cancer Inst. 89:245-250.
8. Combita A. L., Delgado F. G., Rodriguez J. A., Gomez C., and Bravo M. M. 2008. IL-10 expression is associated with lack of HPV-16 E7 specific TH1 response in cervical cancer patients. Rev. Colomb. Cancerol. 12:173-180.
9. de Jong A., van Poelgeest M. I., van der Hulst J. M., Drijfhout J. W., Fleuren G. J., Melief C. J., Kenter G., Offringa R., and van der Burg S. H. 2004. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res. 64:5449-5455.
10. Govan V. A., Constant D., Hoffman M., and Williamson A. 2006. The allelic distribution of 308 TNFa gene polymorphism in South African women with cervical cancer and control women. BMC Cancer 6:24.
11. Hasan U. A., Bates E., Takeshita F., Biliato A., Accardi R., Bouvard V., Mansour M., Vincent I., Gissmann L., Iftner T., Sideri M., Stubenrauch F., and Tommasino M. 2007. TLR9 expression and function is abolished by the cervical cancer-Associated human papillomavirus type 16. J. Immunol. 178:3186-3197.
12. Kanodia S., Fahey L. M., and Kast W. M. 2007. Mechanisms used by human papillomaviruses to escape the host immune response. Curr. Cancer Drug Targets 7:79-89.
13. Lee D. W., Kim Y. T., Kim S. W., Kim S., Kim J. H., Kang M. H., Hwang J. H., and Lim J. 2009. Expression of IL-5 and TNFa in cervical carcinoma. Clin. Vaccine Immunol. 16:959-961.
14. Munagala R., and Nagaraja B. 2008. Alterations in cytokine levels in cervical carcinoma patients through radiation therapy. Curr. Sci. 94:1292-1295.
15. Nicol A. F., Fernandes A. N., and Bonecini-Almeida M. G. 2005. Immune response in cervical dysplasia induced by human papillomavirus: The influence of human immunodeficiency virus-1 co-infection-review. Mem. Inst. Oswaldo Cruz 100:1-12.
16. Passmore J. S., Morroni C., Shapiro S., Williamson A., and Hoffman M. 2007. Papanicolaou smears and cervical inflammatory cytokine responses. J. Inflamm. 4:8.
17. Scott M., Nakagawa M., and Moscickt A. 2001. Cell-mediated immune response to Human papillomavirus infection. Clin. Diagn. Lab. Immunol. 8:209-220.
18. Simoes R. T., Goncalves M. A., Donadi E. A., Simoes A. L., Bettini J. S., Duarte G., Quintana S. M., Carvalho M. W., and Soares E. G. 2005. Association of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intra-epithelial lesions among women in Brazil. J. Clin. Microbiol. 43:3932-3937.
19. Song S. H., Lee J. K., Seok O. S., and Saw H. S. 2007. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix. Gynecol. Oncol. 104:732-738.
20. Stanczuk G. A., Sibanda E. N., Perrey C., Chirara M., Pravica V., and Hutchinson I. V. 2001. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int. J. Cancer 94:792-794.
21. Tjiong M. Y., van der Vange N., ter Schegget J., Burger M. P., ten Kate F. W., and Out T. A. 2001. Cytokines in cervico-vaginal washing fluid from patients with cervical neoplasia. Cytokine 14:357-360.
22. Vinuselvi P., AbiramiVeena V. P., Vani V., and Prasad S. 2008. Yin-yang effect of IL-10 in the incidence of cervical cancer. Adv. Biotech. 2008:26-29.
23. Wanderlei-Silva D, Nobre M., Gonzaga R. S., Viana L. S., and Neto E. R. 2005. High quality DNA from human papillomavirus (HPV) for PCR/RFLP. Braz. Arch. Biol. Technol. 48:37-40.